Skip to content
  • Русский
  • Українська
smart-pharma.group
smart-pharma.group
pharmaceutical consulting services
  • Home
  • Services
  • About Us
  • Pharmacovigilance
    • Report AE
  • Blog
  • Contact Us

Author: admi nistrato

Top M&A Pharma Deals in 2019

04/01/2020 admi nistrato

The year was marked by mergers and acquisitions (M&A) both big and small. Although not comprehensive, here’s a look at…

Continue Reading →

Filed under: AbbVie, acquisitions, Allergan, Bristol-Myers, mergers, Roche, Top M&A Pharma

EAC aims to eliminate duplication of inspections of drug manufacturers

admi nistrato Leave a comment

Public consultations on the draft decision of the EAC Council “Amending the Decision of the Council of the Eurasian Economic…

Continue Reading →

Filed under: EAC, inspections of drug manufacturers, medicinal product, Registration

A modern Center for laboratory testing of drugs and medical products was opened in Kazakhstan

19/12/2019 admi nistrato

Minister of Health of the Republic of Kazakhstan Yelzhan Birtanov within the “Densaulyq” state program of health development of the…

Continue Reading →

Filed under: laboratory testing of drugs and medical devices, Nazarbayev University, Republic of Kazakhstan

An international program for the inspection of sterile drug manufacturers is underway

admi nistrato

The European Medicines Agency (EMA), together with European and international partners, is launching a pilot program to enhance cooperation in…

Continue Reading →

Filed under: EMA, sterile drug manufacturers

Post navigation

Page 5 of 5
← Previous 1 … 4 5

Contact Us

[email protected]

Head office EU:
23 Upes St., Vilnus,
LT-08128, Lithuania

+37 052 060 0 94


CIS office:
26 Peremohy Ave,
Kyiv, 04116, Ukraine

+38 044 390 31 90

Follow Us

EAEU office:
7 Aprelia St., 2/10, 48,
Bishkek, 72007, Kyrgystan

+99 655 007 7073

  • About Us
  • Services
  • Pharmacovigilance
Copyright © 2025 smart-pharma.group